StockWatch
·
Pharmaceuticals
Quarterly Result15 Feb 2026, 05:37 am

Everest Organics Ltd Submits Unaudited Financial Results for Q3 & Nine Months Ended Dec 31, 2025

AI Summary

Everest Organics Limited has submitted its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported a sales turnover of Rs 5026.85 Lakhs for the quarter, with domestic sales at Rs. 3970.75 Lakhs and export sales at Rs. 1056.10 Lakhs. The company operates in one reportable business segment: Active Pharmaceutical Ingredients (APIs) and Intermediates. There were 2,63,157 Equity Share Warrants outstanding on 31.12.2025. The financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors.

Key Highlights

  • Sales turnover of Rs 5026.85 Lakhs for the quarter
  • Domestic sales of Rs. 3970.75 Lakhs and export sales of Rs. 1056.10 Lakhs
  • Operates in the Active Pharmaceutical Ingredients (APIs) and Intermediates segment
  • 2,63,157 Equity Share Warrants outstanding on 31.12.2025
  • Financial results reviewed and approved by the Audit Committee and Board of Directors